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THE SOCIAL CONTEXT OF ONCOFERTILITY
Dorothy E. Roberts*
INTRODUCTION
As more women survive cancer, researchers are developing technol-
ogies that enable these women to become mothers despite the toll the
disease and its treatment can have on their fertility. A field known as
oncofertility provides female cancer patients with a variety of ways to
preserve their fertility so that they may bear genetically related chil-
dren after successful cancer treatment.' Some women delay cancer
therapy so doctors can collect their eggs, which are then cryo-
preserved in an unfertilized state or used to create embryos through in
vitro fertilization (IVF) for freezing.2 When women are healthy again,
they can become pregnant by implanting their stored embryos or the
embryos created from their frozen eggs. An experimental procedure
for preserving the fertility of prepubertal girls, known as ovarian tis-
sue cryopreservation, involves surgically removing their ovarian tissue
and growing the immature eggs to a mature state so they can be fro-
zen and stored until the girls are old enough to bear a child.3
* Kirkland & Ellis Professor, Northwestern University School of Law; faculty fellow, Insti-
tute for Policy Research. This Article in based on my keynote address at the Twenty-first An-
nual DePaul Law Review Symposium, Changing Conceptions: Exploring the Medical and Legal
Advances in Fertility Preservation, on March 11, 2011. I thank Teresa Woodruff, Director of the
Northwestern Oncofertility Consortium, for inviting me to participate in the Consortium and for
her comments on my presentation at the 2011 Oncofertility Consortium Conference. Thanks
also to Mary Anne Case and participants at the Regulation of Family, Sex, and Gender Work-
shop at University of Chicago School of Law and to colleagues at a Northwestern University
School of Law faculty workshop for their comments on a draft of this Article. I am also grateful
to Caroline Goldstein, Marcia Lehr, and Alexius O'Malley for excellent research assistance, and
to the Kirkland & Ellis Fund and the Dorothy Ann and Clarence L. Ver Steeg Distinguished
Research Fellowship for research support.
1. See generally ONCOFERTILITY: ETHICAL, LEGAL, SOCIAL, AND MEDICAL PERSPECTIVES
(Teresa K. Woodruff et al. eds., 2010); Gwendolyn P. Quinn et al., Frozen Hope: Fertility Preser-
vation for Women with Cancer, 55 J. MIDwIFERY & WOMEN's HEALTH 175 (2010); Amanda J.
Redig et al., Commentary, Incorporating Fertility Preservation into the Care of Young Oncology
Patients, CANCER, Jan. 1, 2011, at 4.
2. Susan C. Klock et al., Fertility Preservation for Female Cancer Patients: Early Clinical Expe-
rience, 94 FERTILITY & STERILITY 149 (2010); Audra D. Robertson et al., Embryo Yield After In
Vitro Fertilization in Women Undergoing Embryo Banking for Fertility Preservation Before
Chemotherapy, 95 FERTILITY & STERILITY 588 (2011).
3. Cynthia B. Cohen, Ethical Issues Regarding Fertility Preservation in Adolescents and Chil-
dren, 53 PEDIATRIC BLOOD & CANCER 249 (2009); Gregory Dolin et al., Medical Hope, Legal
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Ethical questions raised by fertility preservation are not confined to
the clinic and bedside; rather, these questions extend to the impact of
fertility preservation on society and the way social forces influence
women's decisions about their fertility. Discussions about the ethics
of preserving the fertility of women and girls who survive cancer must
take into account the fact that reproductive decision making occurs in
a social context. Gender, class, and race inequities help determine the
reproductive options available to women, such as a woman's access to
assisted reproductive technology (ART), and the consequences that a
woman's childbearing decisions have for her, her family, and her com-
munity. This social context is important despite the distinction some
scholars make between "medical" and "social" reasons for freezing
eggs, distinguishing infertility caused by disease or treatments for dis-
ease from infertility caused by delaying childbearing.4 Although
oncofertility procedures respond to a medical need, "disease-related
egg freezing" operates in a social context as much as "age-related egg
freezing" does.5
Similarly, scientific innovations such as fertility-preserving technol-
ogies are not neutral tools that have a pre-determined intrinsic value.
Rather, their use is shaped by their interaction with ideologies and
structures of power, including hierarchies of race, class, and gender,
and related social views. But this is not a unidirectional effect of
society-influencing technology: new forms of science and power
emerge simultaneously.6 The uses and outcomes of novel technologies
like oncofertility are determined by their social context at the same
time that these technologies have an impact on society. Fertility pres-
ervation has the power to reinforce or subvert social structures and
norms marked by gender, race, class, and other inequities.
There is a public as well as personal stake in policies regarding fer-
tility preservation. Procreation's special status stems as much from its
role in social structure and political relations as from its significance to
Pitfalls: Potential Legal Issues in the Emerging Field of Oncofertility, in ONCOFERTILITY: ETHI-
CAL, LEGAL, SOCIAL, AND MEDICAL PERSPECTIVES, supra note 1, at 111, 123; Catherine Poirot
& Benoit Shubert, Fertility Preservation in Prepubertal Children, 98 BULL. CANCER 489 (2011).
4. See NAOMI R. CAHN, TEST TUBE FAMILIES: WHY THE FERTILITY MARKET NEEDS LEGAL
REGULATION 134-35 (2009) (distinguishing between medical, structural, and cultural infertility);
Angel Petropanagos, Reproductive 'Choice'and Egg Freezing, in ONCOFERTILITY: ETHICAL, LE-
GAL, SOCIAL, AND MEDICAL PERSPECTIVES, supra note 1, at 223, 224. As I discuss in Part IV,
this dichotomy typically omits the social reasons why African-American women disproportion-
ately suffer from medical infertility as well as the way incarceration disproportionately compels
them to delay childbearing. See infra notes 87-89 and accompanying text.
5. Petropanagos, supra note 4, at 224 (emphasis omitted).
6. See generally JENNY REARDON, RACE TO THE FINISH: IDENTITY AND GOVERNANCE IN AN
AGE OF GENOMICS (2005).
778 [Vol. 61:777
2012] THE SOCIAL CONTEXT OF ONCOFERTILITY
individuals.7 Women of color who advocate for reproductive justice
distinguish between traditional notions of reproductive choice that
center on freedom from state interference in an individual woman's
procreative decisions and a more politically conscious approach that
places procreative decision making in its social context.8 A reproduc-
tive justice framework examines how inequities based on systems of
power create barriers to reproductive freedom, forming a reproduc-
tive hierarchy in which some women's childbearing is valued more
than others. This approach acknowledges the justice of ensuring
equal access to family planning without denying the injustice of im-
posing contraception as a means of population control and a solution
to social problems. Reproductive justice advocates treat the legal
fight for reproductive freedom as part of a larger struggle to create a
more egalitarian society.
Because it is unethical for the government to limit childbearing by
socially disadvantaged women in order to improve society, state provi-
sion of family planning must be contingent on improvements in gen-
eral health and living conditions. Eugenic policies aimed at reducing
the births of socially devalued groups perpetuate the myth that dispar-
ities in wealth, health, and education are caused by the victims of in-
equitable social structures. At the same time, once those seeking
high-tech fertility preservation ask the government to devote public
funds or mandate private spending to support their reproductive deci-
sions, the public may evaluate the social costs and benefits of investing
in these technologies not only for individual patients, but also for the
broader society. Does state investment in oncofertility research and
procedures constitute a just distribution of public resources?
Considering the role social context plays in the ethics of fertility
preservation reveals several paradoxical tensions that policy makers
will have to resolve. First, on one hand, oncofertility promotes gender
equity by providing female cancer patients the opportunity to bear a
child and by placing them on equal footing with their male counter-
parts. On the other hand, oncofertility may help to reinforce the
gender-biased assumption that all women should become mothers,
ideally by bearing children who are genetically related to them. Sec-
ond, expanding private insurance coverage of oncofertility procedures
will help to extend access to women who cannot afford to pay for
7. See generally DOROTHY ROBERTS, KILLING THE BLACK BODY: RACE, REPRODUCTION,
AND THE MEANING OF LIBERTY 294-312 (1997); RICKIE SOLINGER, PREGNANCY AND POWER: A
SHORT HISTORY OF REPRODUCTIVE POLITICS IN AMERICA (2005).
8. See generally ROBERTS, supra note 7; JAEL SILLIMAN ET AL., UNDIVIDED RIGHTS: WOMEN
OF COLOR ORGANIZE FOR REPRODUCTIVE JUSTICE (2004).
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them. Yet it may also increase gaps in access to ART by privileging
those who are already the most economically advantaged. In addi-
tion, while subsidizing oncofertility may give women of color greater
access to high-tech medical care, such subsidies may mask deeper in-
equities that produce racial disparities in reproductive health.
II. GENDER INEQUALITY AND REPRODUCTIVE DECISIONS
Does oncofertility promote gender equality by giving female cancer
patients the reproductive options men have, or does it reinforce
"repronormativity" by fulfilling the expectation that all women will
become mothers? 9 A key objective of oncofertility research is to give
women undergoing cancer treatment the means to fulfill their desire
to bear a child. The procedure expands the reproductive options
these women have, allowing them to choose whether or not to have a
child despite experiencing fertility loss as a result of cancer. Megan
Faurot and Teresa Woodruff, Director of the Northwestern Oncofer-
tility Consortium (Consortium) and a leading pioneer in the field, de-
scribe the "driving force" of the university initiative as "[s]upporting
the oncofertility patient decision-making process with improved pres-
ervation options."' 0 Thus, oncofertility furthers a hallmark of
women's liberation during the last century-women's ability to make
decisions about their childbearing." According to this view, it ex-
pands the range of women's choices rather than influencing what their
choices should be.
Fertility preservation places women on equal footing with men, who
can more easily safeguard their ability to have genetically related chil-
dren by collecting and storing their sperm. Woodruff focuses on this
aspect of gender equity in explaining the original mission of the Con-
sortium, noting that prior to the development of oncofertility proce-
dures, "[w]omen had the same hope for survival as men but fewer
reproductive options."i 2 This observation reflects the gender-
equalizing function of egg freezing outside the context of cancer. As
9. See generally Katherine M. Franke, Essay, Theorizing Yes: An Essay on Feminism, Law,
and Desire, 101 COLUM. L. REV. 181 (2001).
10. Megan Faurot & Teresa K. Woodruff, The Oncofertility Saturday Academy: A Paradigm to
Expand the Educational Opportunities and Ambitions of High School Girls, in ONCOFERTILITY:
ETHICAL, LEGAL, SOCIAL, AND MEDICAL PERSPECTIVES, supra note 1, at 321, 321.
11. See Planned Parenthood of Se. Pa. v. Casey, 505 U.S. 833 (1992) (recognizing the right of
women to choose to have an abortion before viability); Reva Siegel, Reasoning from the Body: A
Historical Perspective on Abortion Regulation and Questions of Equal Protection, 44 STAN. L.
REV. 261 (1992).
12. Teresa Woodruff, Opening Address at the Northwestern Oncofertility Consortium Annual
Conference: Oncofertility: Five Years Ago, Five Years Ahead (Sept. 12, 2011), available at http://
oncofertility.northwestern.edu/medialoncofertility-five-years-ago-five-years-ahead.
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Adrienne Asch notes, "Egg-freezing might lessen women's sense of
having a 'biological clock,' and could give them some of the freedom
men have always enjoyed about whether and when to reproduce."13
Proponents of oncofertility recognize that many women want to be-
come mothers and suffer when they are unable to have a desired child.
Preserving cancer patients' fertility fulfills the duty to repair what can-
cer and its treatment have broken, restoring the procreative capacity
that most women find important to their identity, well-being, and hap-
piness. 14 A recent study of 240 female cancer survivors compared the
psychosocial adjustment of 77 of the women who sought infertility
treatment but remained childless to the rest of the sample.15 Perhaps
unsurprisingly, these women reported significantly more infertility-
related trauma symptoms, greater distress about infertility, and lower
sexual and relationship satisfaction than the other cancer survivors,
especially if they were childless.' 6 Oncofertility compassionately re-
sponds to the distress from infertility experienced by women like
these and helps them realize their desire to have children.
Although fertility preservation adds to the reproductive options
available to female cancer patients, one might ask why it is so impor-
tant to many women to preserve the capacity to become a mother.
Does the desire to preserve this option and the distress from losing it
stem in part from a gender injustice? Some feminist scholars have
worried that infertile women seek out ART in part because of the
unjust expectation that all women will become mothers and the social
stigma surrounding infertility.' 7 These scholars question the forces
that drive so many women to endure the physical and emotional toll
entailed in some forms of assisted reproduction. Freezing eggs in-
volves first stimulating ovulation with daily hormone injections and
retrieving eggs from the ovaries-a painful, risky, and costly process.
13. Adrienne Asch, The Lessons of Oncofertility for Assisted Reproduction, in ONCOFER-
TILYTY: ETHICAL, LEGAL, SOCIAL, AND MEDICAL PERSPECTIVES, supra note 1, at 181, 184.
14. See Laurie Zoloth, Keynote Address at the Northwestern Oncofertility Consortium An-
nual Conference: The Duty of Repair in a Broken World: Ethical Questions After Five Years of
Oncofertility Research (Sept. 12, 2011), available at http://oncofertility.northwestern.edu/media/
keynote-duty-repair-broken-world-ethical-questions-after-five-years-oncofertility-research.
15. Andrea L. Canada & Leslie R. Schover, The Psychosocial Impact of Interrupted
Childbearing on Long-Term Female Cancer Survivors, 21 PSYCHO-ONCOLOGY 134 (2012).
16. Id.
17. See generally BARBARA KATZ ROTHMAN, RECREATING MOTHERHOOD: IDEOLOGY AND
TECHNOLOGY IN A PATRIARCHAL SOCIETY (1989). See also Angela Y. Davis, Outcast Mothers
and Surrogates: Racism and Reproductive Politics in the Nineties, in AMERICAN FEMINIST
THOUGHT AT CENTURY'S END 355, 360 (Linda S. Kauffman ed., 1993) (noting that "infertile
women-or the wives/partners of infertile men-who are financially able to do so are increas-
ingly expected to try everything," resulting in "an ideological compulsion" toward creating a
child).
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After this bodily trauma, the procedure may lead to further heart-
break if it fails to produce a live baby. According to Katherine
Franke, women are held to a standard of repronormativity that en-
compasses "the complex ways in which reproduction is incentivized
and subsidized in ways that may bear upon the life choices women
face."18 As I discuss in Parts III and IV, the government's incentiviz-
ing and subsidizing of reproduction does not apply equally to all
women. Women of color in particular have been subject to policies
designed to deter them from having children. Still, all women are af-
fected by societal and cultural norms that associate the ideal female
identity with motherhood. It is hard to disentangle the desperation
for a child that leads some women to use ART from the pressure on
them to meet this maternal standard.
The above-mentioned study of psychosocial distress in cancer survi-
vors who seek infertility services also found that an unfulfilled desire
to have a child was not associated with a higher level of general emo-
tional distress or with poorer mental health. The authors concluded
that "[i]n general, women in our sample had good overall psychologi-
cal adjustment. . . . Thus, the distress appears to be limited to the
fertility issue." 19 This finding has been confirmed by several studies
showing that "[pisychological distress diminishes over the first year
after breast cancer diagnosis, but sexual dysfunction, menopausal
symptoms, and infertility-related distress remain severe and perva-
sive." 20 It is possible that the distress from infertility and stress in
relationships these cancer survivors feel stem partly from the stigma
they experience because they are unable to bear a child.
Just as infertility is stigmatized, so too is a woman's deliberate deci-
sion not to have children. In fact, it is considered downright unnatu-
ral. As Joan Callahan and I observed, "Our society does not think it is
just fine for people to remain single and childless deliberately or for
married people to remain childless deliberately. Infertility is con-
structed as a nearly unbearable tragedy; deliberate childlessness is
constructed as nearly unimaginable selfishness."2 1 So if the option of
egg freezing is available, some women may feel a duty to take advan-
tage of it. When these social pressures are considered, it is harder to
tell whether oncofertility only expands women's options and freedom,
18. Franke, supra note 9, at 184.
19. Canada & Schover, supra note 15, at 140.
20. Leslie R. Schover et al., Sisters Peer Counseling in Reproductive Issues After Treatment
(SPIRIT), 117 CANCER 4983, 4983 (2011).
21. Joan C. Callahan & Dorothy E. Roberts, A Feminist Social Justice Approach to
Reproduction-Assisting Technologies: A Case Study on the Limits of Liberal Theory, 84 Kv. L.J.
1197, 1225 (1996).
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or whether it also contributes to the compulsion some women feel to
be mothers.
The normative force of these social pressures is so strong and perva-
sive that there is a tacit assumption that all women cancer patients
would want to preserve their fertility if the technology is perfected
and available. Because the desire to have children is taken for
granted, fertility preservation seems like an act of restoring nature,
simply putting the woman back to normal. The underlying cultural
expectation remains unnoticed. It may be easier, then, for technology
to solve the problem in nature (infertility) than for society to tackle
the problem in culture (the expectation that all women will be
mothers). 22
Added to this expectation of motherhood is the exclusive notion of
genetic parenthood. 23 Reproduction-assisting technologies do not
simply permit infertile people to have children; they permit them to
have children who are genetically related to them. If a cancer survivor
decides to become a mother, she can fulfill this desire by adopting a
child. She can also form a close bond with a child by helping to care
for someone else's child.24 Egg freezing is required only to ensure
that women have children who are genetically related to them. This
preference for biological ties over social ones unjustly gives greater
value to genetic relatedness at a time when there are thousands of
children available for adoption in the public foster care system and
when many mothers would welcome assistance with caring for their
children.25 It falsely suggests that we are only capable of loving chil-
dren who share our genes.
The argument to prioritize adoption over fertility preservation is
complicated in the case of cancer survivors. Researchers have discov-
ered that cancer survivors often lack information about adoption and
face discrimination by adoption agencies. 26 Some agencies disqualify
cancer survivors on the basis of vague standards for determining the
22. See Franke, supra note 9, at 185 & n.15.
23. See generally Dorothy E. Roberts, The Genetic Tie, 62 U. CHI. L. REv. 209 (1995).
24. For a discussion of the African-American practice of "other mothering," see PATRICIA
HILL COLLINS, BLACK FEMINIST THOUGHT: KNOWLEDGE, CONSCIOUSNESS, AND THE POLITICS
or EMPOWERMENT 182, 192-93 (2d ed. 2000); CAROL B. STACK, ALL OUR KIN: STRATEGIES FOR
SURVIVAL IN A BLACK COMMUNITY (1974).
25. For a critical discussion of the large and disproportionate numbers of African-American
children in foster care, see DOROTHY ROBERTS, SHATTERED BONDS: THE COLOR OF CHILD
WELFARE (2002). There, I argue that a goal of child welfare policy should be to reduce the
numbers of children placed in foster care and in need of adoption by supporting families, rather
than to fulfill the desires of adults who wish to adopt.
26. See generally Shauna L. Gardino et al., Adoption After Cancer: Adoption Agency Attitudes
and Perspectives on the Potential to Parent Post-Cancer, in ONCOFERTILITY: ETHICAL, LEGAL,
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"welfare of the child" that include medical conditions and lifestyle
characteristics. 27 In the free-market ethos governing the adoption
process, "[a]n individual with a clean medical history competing
against a cancer survivor to adopt a child would arguably receive pref-
erential treatment." 28
The tension between these competing gender-equity claims is espe-
cially acute in the ethics of preserving the future reproductive capacity
of girls. Although ovarian tissue cryopreservation would expand a
girl's future reproductive options, she might perceive the decision
made by others to preserve her fertility as additional pressure to have
a child. "[A] competent adult can consent to almost any legal medical
procedure, including one that will permanently alter his or her repro-
ductive capacities." 29 Minors, however, cannot decide for themselves.
Parents are typically vested with the legal authority to make medical
decisions for their minor children. 30
When parents consent to fertility-preserving surgery for their
daughter, they may be giving her the same reproductive flexibility that
a son who survives cancer would enjoy when deciding whether or not
to have genetically related children. Their decision may save her from
the trauma of discovering when she reaches childbearing age that she
is incapable of bearing the child she desires. But her parents may also
be intensifying the gendered expectations their daughter will confront.
Now, not only will she experience the general norm to become a
mother, but she will also feel the added expectation exerted by the
existence of the eggs that have been extracted, matured, frozen, and
stored at great expense just for this purpose. Some parents may even
be motivated more by their own desire to have grandchildren than by
their desire for their daughter to have greater reproductive autonomy.
Is this any different, though, from the typical parents who encourage
their daughters in subtle and not-so-subtle ways to become mothers?
It can be argued that banked eggs exert no more undue pressure than
a bank account that parents maintain as an incentive for their children
to attend college. 31
SOCIAL, AND MEDICAL PERSPECTIVES, supra note 1, at 153; Allison Rosen, Third-Party Repro-
duction and Adoption in Cancer Patients, 34 MONOGRAPHS 91 (2005).
27. Gardino et al., supra note 26, at 153.
28. Id. at 163.
29. Dolin et al., supra note 3, at 116.
30. See Barbara J. Stegmann, Unique Ethical and Legal Implications of Fertility Preservation
Research in the Pediatric Population, 93 FERTILITY & STERILITY 1037 (2010) (discussing the po-
tentially coercive nature of such decisions).
31. Lisa Campo-Engelstein, Preserving the Right to Future Children: An Ethical Case Analysis,
12 AM. J. BIOETHICS (forthcoming 2012).
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On the one hand, we might compare failing to agree to an oncofer-
tility procedure for a girl to actively sterilizing her, a procedure con-
sidered so extraordinary that it requires judicial approval. 32 In both
cases, it could be argued, the parents are depriving their daughter of
the ability to have a child in the future. (Of course, sterilization is an
affirmative act that destroys someone's reproductive capacity, which
can be distinguished from not acting to restore reproductive capacity
that has been destroyed by cancer.) On the other hand, we might be
concerned that consenting to fertility-preserving surgery exerts undue
interference with the child's own identity, making the surgery more
comparable to sex assignment surgery performed on babies with am-
biguous genitalia. Although sex assignment surgery is currently en-
couraged by many pediatricians, it has come under fire for foreclosing
the child's right to an "open future."33 (Of course, sex assignment
surgery has a more constraining effect on a child's identity than does
removing and preserving a girl's ovaries.) The opposite analogy could
also be made: failing to preserve a girl's fertility forecloses an open
future because it deprives the girl of the future ability to decide to
bear children. Both preserving a daughter's fertility and failing to pre-
serve it will have a tremendous impact on the girl's future.
Recognizing the influence of gender-biased norms on women's re-
productive decision making, however, does not necessarily mean that
fertility preservation is unethical because it reinforces gender bias.
First, not all feminists agree that ART necessarily imposes patriarchal
norms on women.34 Indeed, assuming that cancer patients who pre-
serve their fertility are bowing to patriarchal pressures treats women
paternalistically. Respecting women's autonomy requires providing
them with the means to fulfill their reproductive decisions and not to
question the reasons for those decisions. The danger of government
scrutiny of people's motives for their reproductive decisions overrides
concern about reinforcing gender norms. As Tabitha Powledge wrote
about sex selection, "I hate these technologies, but I do not want to
see them legally regulated because, quite simply, I do not want to pro-
32. Dolin et al., supra note 3, at 120, 123-24.
33. Id. at 120.
34. See CHARIS THOMPSON, MAKING PARENTS: THE ONTOLOGICAL CHOREOGRAPHY OF
REPRODUCTIVE TECHNOLOGIES 70 (2005) (noting that a new generation of feminist theorists see
in ART "the potential to articulate new ways of embodying reproduction, some of which would
disrupt conventional families and gender stereotypes" and that "they refused to read ARTs as
simply signing and sealing preexisting oppressive social orders"). While some cancer survivors
may use ART to challenge gender norms, the oncofertility field has not generally embraced this
mission and typically helps cancer survivors form traditional marital families with genetically
related children.
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vide an opening wedge for legal regulation of reproduction in
general."35
After all, cancer patients and others who are infertile should not
have to sacrifice their procreative desires for the sake of ending dis-
criminatory gender norms. Protection of individuals' procreative lib-
erty should prohibit state intervention in the choice to use
oncofertility as long as that choice itself does not harm anyone.
Yet, a liberal approach to ART dedicated solely to protecting indi-
vidual choices from state interference, but not from market and social
inequities, fails to address major impediments to women's freedom
under the neoliberal conditions that exist today. As the members of
the Alliance for Humane Biotechnology observe, "The need for secur-
ing a woman's right to choose that found moorings in a liberal state
experimenting with health and welfare programs plays out quite dif-
ferently in the techno-libertarian context where radical individualism
denies the interconnectedness of human relations." 36 Even the liberal
state to which the authors refer denied the right to public funding for
abortion services, leaving some women who could not afford this form
of medical care unable to choose to terminate an unwanted preg-
nancy.37 In recent decades the state has drastically slashed social pro-
grams, including those that assist struggling mothers, while promoting
the free-market conditions conducive to capital accumulation.38 Criti-
cal to this process of state restructuring is the transfer of services from
the welfare state to the private realms of market, family, and individ-
ual; the reliance on individualized technological solutions for social
wrongs; and the neglect of people who cannot succeed in the free mar-
ket.3 9 The goal of public policy should be to protect and support a
woman's decision to have a child, including the provision of resources
35. Tabitha M. Powledge, Unnatural Selection: On Choosing Children's Sex, in THE CUSTOM-
MADE CHILD? wOMEN-CENTERED PERSPECTIVES 193, 197 (Helen B. Holmes et al. eds., 1981);
see also GENERATIONS AHEAD, POSITION STATEMENT ON LEGISLATION BANNING ABORTION
FOR REASONS OF SEX OR RACE, available at http://www.generations-ahead.org/files-for-
download/success-stories/pslegislationl.pdf ("Our real challenge is to change the context in
which sex selection and racial disparities develop, addressing gender and racial equality issues
while protecting the right of all women to make the best reproductive decisions for themselves
and their families.").
36. Tina Stevens et al., Finding the Active Voice: The Challenge of Developing Prochoice Reg-
ulation of ARTs, GENE WATCH, June-July 2011, at 23, 23.
37. ROBERTS, supra note 7, at 229-32; see also Harris v. McRae, 448 U.S. 297 (1980) (uphold-
ing the constitutionality of public funding restrictions for medically necessary abortions.)
38. See generally NOAM CHOMSKY, PROFIT OVER PEOPLE: NEOLIBERALISM AND GLOBAL OR-
DER (1999); DAVID HARVEY, A BRIEF HISTORY OF NEOLIBERALISM (2005).
39. See DOROTHY ROBERTS. FATAL INVENTION: How SCIENCE, POLITICS, AND BIG BUSINESS
RE-CREATE RACE IN THE TWENTY-FIRST CENTURY 300-02 (2011); Lorc WACQUANT, PUNISHING
THE POOR: THE NEOLIBERAL GOVERNMENT OF SOCIAL INSECURITY (2009).
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needed for care giving, while eliminating the gender-biased stigma di-
rected at women who do not have children.
Second, some of the concerns underlying feminist objections to cer-
tain ART do not apply to oncofertility. One reason for the infertility
of well-educated, high-income women is their postponement of
childbearing in order to pursue a career. The root cause of these
women's infertility is not biological; rather, it is a workplace that
makes it extremely difficult for women to combine employment and
childbearing.40 Using ART to treat infertility caused by postponed
childbearing, some argue, "could divert attention away from the social
structures that pressure women to delay child-bearing in the first
place." 4 1 By freezing their eggs, these women can bypass this social
problem through technological intervention without eliminating the
structural unfairness that forced them to choose between a career and
motherhood. But cancer patients who become infertile are not suffer-
ing from a discriminatory system that should be fixed. Infertility
caused by cancer does not result from unequal social structure in the
same way as infertility caused by women's careers. In this respect, the
distinction between medical and structural infertility noted in the in-
troduction is relevant to the ethics of oncofertility.
At the same time, there may not be such a neat distinction between
medical and structural infertility in all cases. An article on the
psychosocial impact of infertility on female cancer survivors begins by
noting how the two types of infertility may be intertwined:
More women are delaying pregnancy until their thirties, only to
have cancer interrupt their life plans. By age 39, one in 51 women
will be diagnosed with an invasive cancer. Treatment for cancers
most common in premenopausal women often decreases fertility or
leads to permanent ovarian failure.42
In other words, some cancer patients may be childless and desire to
become pregnant for the first time during treatment because they
postponed childbearing until an age when they have a greater risk of
getting cancer. Freezing these patients' eggs is not really a distinctive
kind of fertility preservation-prior to cancer treatment these women
had the same reduced fertility as other women their age who do not
have cancer. One might see oncofertility in these cases as deflecting
attention from the underlying social reasons that led the patients to
40. See generally JOAN WILLIAMS, UNBENDING GENDER: WHY FAMILY AND WORK CONFLICT
AND WHAT TO Do ABOUT IT (2000).
41. Asch, supra note 13, at 184; see also Michele Goodwin, Assisted Reproductive Technology
and the Double Bind: The Illusory Choice of Motherhood, 9 J. GENDER, RACE & JUST. 1 (2005).
42. Canada & Schover, supra note 15, at 134 (footnotes omitted).
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put off pregnancy until an age when they were more vulnerable to
both cancer and infertility.
Another set of concerns that has less relevance to oncofertility has
to do with the commodification of women's bodies and reproductive
labor that results from egg donation and surrogacy.43 The sale of eggs
and renting of wombs create a market in women's reproductive labor
that exploits and devalues the less privileged women who provide pro-
creative goods and services to those more privileged. According to
Kathy Sloan, a human rights advocate specializing in global feminism,
the troubling issues raised by surrogacy include:
the ethical and practical ramifications of the further commodifica-
tion of women's bodies (beyond universal sexual commodification);
exploitation of poor and low income women; implications for
women's reproductive rights if embryos become legally defined;
rights of the children produced to information regarding their ge-
netic history and any siblings they may have who are the offspring
of the donor parents; prevention and prosecution of fraud by surro-
gacy companies; and the moral and ethical consequences of trans-
forming a normal biological function of a woman's body into a
commercial contract.44
These harms of commercialized third-party reproduction do not occur
when women preserve their own eggs for future fertilization and im-
plantation unless they hire a surrogate to gestate the baby. Although
cancer patients must pay medical expenses and storage fees, there is
no commercial exchange for their eggs or wombs.
Oncofertility is not immune to the commercial pressures that gov-
ern ART, however, and some dangers highlighted by feminist critics
of ART apply. One of the main concerns for women who supply eggs
for ART is the risk to their health caused by the procedures required
for egg retrieval. The multiple injections of hormones to stimulate
their ovaries to produce eggs and surgeries to harvest these eggs have
been associated with short- and long-term injuries, including ovarian
hyperstimulation syndrome, ovarian cysts, infection, bleeding, kidney
failure, stroke, cancer, and infertility.45 Despite evidence of medical
43. See generally MARGARET JANE RADIN, CONTESTED COMMODITIES (1996); FRANCE WIND-
DANCE TWINE, OUTSOURCING THE WomB: RACE, CLASS, AND GESTATIONAL SURROGACY IN A
GLOBAL MARKET (2011); Debra Satz, Markets in Women's Reproductive Labor, 21 PHIL. & PUB.
AFF. 107 (1992).
44. Kathy Sloan, Abuses of Women's Human Rights in Third Party Reproduction, GENE
WATCH, June-July 2011, at 20, 21.
45. See Jaime F. Avecillas et al., Ovarian Hyperstimulation Syndrome, 20 CRITICAL CARE
CLINICS 679 (2004); Joseph G. Whelan III & Nikos F. Vlahos, The Ovarian Hyperstimulation
Syndrome, 73 FERTILITY & STERILITY 883 (2000); Kenneth H.H. Wong, Ovarian Hyperstimula-
tion Syndrome, in REPRODUCTIVE ENDOCRINOLOGY & INFERTILITY: INTEGRATING MODERN
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risks, there are no registries or studies that track the long-term health
outcomes of egg donors, nor any state or federal regulation requiring
the fertility industry to investigate and report these risks, owing in
part to resistance from the multibillion dollar fertility business.4 6
These health risks exist whether a woman has her eggs harvested for
pay or to preserve her own fertility (depending on how many eggs are
harvested), and she should have the information needed to weigh
these risks against the potential benefits of future childbearing. 4 7
Given the ordinary health risks of egg harvesting, combined with addi-
tional interference with their cancer treatment, some women may pre-
fer a less hazardous alternative, such as adoption or remaining
childless.
One way out of the gender-equity paradox described above is to
implement procedures to reduce the pressures female cancer patients
feel to have genetically related children. Advocates who are working
to ensure that oncologists inform their patients about fertility preser-
vation should also work to ensure that women and girls are not pres-
sured into freezing their eggs. Rather than assume that fertility
preservation makes all women patients better off, women should be
able to assess the risks of the procedure and alternatives to bearing a
child, such as adopting a child, being a fulfilled woman who is child-
less, or helping to mother other women's children. Recognizing the
gendered expectations weighing on women makes fully informed con-
sent, safeguards against physician conflicts of interest, and other pro-
tections of patient autonomy especially important. Oncofertility
programs should also include efforts to remove barriers to adoption
faced by cancer survivors.
Are these protections of patient autonomy enough? The focus of
traditional bioethics on patient autonomy in the clinical context tends
to neglect the social context of patient decision making and equally
important questions of social equality and justice.48 In evaluating the
best use of public investment, we might want to promote adoption by
discouraging fertility preservation. Finding no support for the neces-
sity of genetic parenting, Carolyn McLeod argues, "To offset the bias
CLINICAL AND LABORATORY PRACTICE 711 (Douglas T. Carrell & C. Matthew Peterson, eds.,
2010).
46. Catherine Elton, As Egg Donations Mount, So Do Health Concerns, TIME (Mar., 31,
2009), available at http://www.time.com/time/health/article/0,8599,1888459,00.html.
47. See Sonia M. Suter, Giving In to Baby Markets: Regulation Without Prohibition, 16 MICH.
J. GENDER & L. 217, 242-51 (2009) (describing the risks entailed in egg donation and proposing
enhanced informed consent requirements).
48. See, e.g., Tom L. BEAUCHAMP & JAMES F. CHILDRESS, PRINCIPLES OF BIOMEDICAL ETH-
Ics (6th ed. 2009).
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that our society has toward biologic parenting, perhaps we ought to
encourage non-biologic parenting for infertile cancer survivors, for in-
fertile people in general, or for everyone for that matter." 49 McLeod
points to psychological studies indicating that infertile people who
adopt children have levels of well-being similar to those who succeed
with fertility treatments.50 The just allocation of public resources may
warrant their investment in adoption for cancer survivors rather than
in preserving their fertility. This investment approach might take the
form of refusing to subsidize fertility preservation procedures either
through state funding or insurance mandates. But is it just to deny
these procedures to the majority of women when affluent women who
can afford it have access to them? The next Part will address that
question.
III. ECONOMIC INEQUALITY AND ACCESS TO ONCOFERTILITY
Harvesting and storing eggs is expensive. The average facility
charge alone for ovarian tissue cryopreservation has been approxi-
mately $30,000.51 The average cost of an IVF cycle is approximately
$12,500, and the average cost per live birth is more than $40,000.52 So
poverty and low incomes, combined with other social barriers, keep
many women from using fertility preservation services. As Mary Lyn-
don Shanley and Adrienne Asch observe, "Poorer women and those
who lack health insurance are less likely to go to a doctor for fertility
assistance, and race, education level attained, marital or cohabitation
status, and socioeconomic status all affect access to fertility ser-
vices." 53 At present, "insurance coverage for fertility preservation is
not mandated nationally or in any state, making it unaffordable for
the majority of eligible women."54 Some oncofertility programs are
lobbying state legislatures to require private insurance companies to
include fertility preservation in their coverage.55
49. Carolyn McLeod, Morally Justifying Oncofertility Research, in ONCOFERTILITY: ETHICAL,
LEGAL, SOCIAL, AND MEDICAL PERSPECTIVES, supra note 1, at 187, 191 (citation omitted).
50. Id.
51. Shauna L. Gardino et al., Anticipating Ovarian Tissue Cryopreservation in the Health-Care
Marketplace: A Willingness to Pay Assessment, in ONCOFERTILITY: ETHICAL, LEGAL, SOCIAL,
AND MEDICAL PERSPECTIVES, supra note 1, at 363, 365.
52. Georgina M. Chambers et al., The Economic Impact of Assisted Reproductive Technology:
A Review of Selected Developed Countries, 91 FERTILITY & STERILITY 2281, 2291 (2009).
53. Mary Lyndon Shanley & Adrienne Asch, Involuntary Childlessness, Reproductive Tech-
nology, and Social Justice: The Medical Mask of Social Illness, 34 SIGNS 851, 856 (2009).
54. Canada & Schover, supra note 15, at 135 (footnotes omitted).
55. See Lisa Campo-Engelstein, For the Sake of Consistency and Fairness: Why Insurance
Companies Should Cover Fertility Preservation Treatment for latrogenic Infertility, in ONCOFER-
TILITY: ETHICAL, LEGAL, SOCIAL, AND MEDICAL PERSPECTIVES, supra note 1, at 381, 385.
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Will subsidizing fertility preservation help to reduce economic dis-
parities in reproductive health by increasing access to these proce-
dures, or will it privilege those women who are already the most
economically advantaged? The unequal distribution of wealth in our
society prevents less affluent people from buying countless goods and
services that wealthy people can afford. One might argue that, while
these financial barriers are unfortunate, they do not justify interfering
with those fortunate enough to have access to oncofertility. Nor does
the right to use ART necessarily entail the governmental obligation to
provide access to such technology. Medical innovations often increase
inequality because wealthy people start from an advantaged position
and are better able to make use of them. 5 6 Yet this is no reason to
stifle medical progress and access to its benefits by those who can af-
ford it.
But there is a compelling counterargument that the social harm that
stems from confining fertility preservation in the hands of wealthy
people is reason to ensure equalized access to oncofertility. Procrea-
tion holds a special status central to "personal identity, to dignity, and
to the meaning of one's life"57 and recognized by the Supreme Court
of the United States as "one of the basic civil rights of man." 58
Procreative liberty's importance to human dignity is a compelling rea-
son to guarantee the equal distribution of procreative resources in so-
ciety. Conversely, privileging procreation by social elites while
devaluing procreation by socially disadvantaged groups historically
has been a chief form of state oppression. 59 Wealth, like gender,
should not determine which cancer survivors are able to have a child.
Proposals to mandate insurance coverage provide only a limited fi-
nancial resource, however, one that will do little to bridge the huge
lacuna between the ART available to rich and poor women. Indeed,
subsidizing oncofertility for people who have private health insurance
without ensuring equal access to low-income and poor patients will
privilege those who are already better off, only increasing economic
disparities. Millions of women are not covered by private health in-
surance and rely on Medicaid to pay for their medical care.60 Medi-
56. Bruce G. Link & Jo C. Phelan, Fundamental Sources of Health Inequalities, in POLICY
CHALLENGES IN MODERN HEALTH CARE 71, 80 (David Mechanic et al. eds., 2005).
57. JOHN A. ROBERTSON, CHILDREN OF CHOICE: FREEDOM AND THE NEW REPRODUCTIVE
TECHNOLOGIES 24 (1994).
58. Skinner v. Oklahoma, 316 U.S. 535, 541 (1942).
59. EDWIN BLACK, WAR AGAINST THE WEAK: EUGENICS AND AMERICA'S CAMPAIGN TO
CREATE A MASTER RACE (2003); DANIEL J. KEVLES, IN THE NAME OF EUGENICS (1995).
60. By Population, MEDICAID.Gov, http://www.medicaid.gov/Medicaid-CHIP-Program-Infor-
mation/By-Population/By-Population.htmI ("Medicaid provides health coverage to 11 million
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caid covers only medically necessary procedures,6' and infertility
treatment is considered elective. So while women who are covered by
private insurance, probably through their employers, would have ac-
cess to fertility preservation, poor women who rely on Medicaid
would not.
Even if the state were to provide minimal subsidies for fertility pres-
ervation by low-income and poor women, wealthy women would have
access to more advanced technologies and would be able to pay for
additional services. If the state or insurance companies pay for one
round of IVF, for example, the affluent can pay for several. Wealthier
women can also afford genetic testing, sex selection, and even so-
called "cosmetic" genetic screening to enable them not only to have a
genetically related child, but also to have a child with preferred ge-
netic traits.62 Policies that increase access to fertility preservation
raise the ethical question of how much equality the public is willing to
support.
Expanding state subsidies for ART to close the economic access
gap, in turn, raises the question of whether the just distribution of
public resources warrants such a large investment in technologically
enhanced fertility. Can the government ethically channel millions of
health care dollars to enable cancer survivors to have genetically re-
lated children rather than spending similar amounts on programs that
would provide more extensive benefits to infertile people in particular
and public health in general? Research designed to reduce infertility
and the universal provision of basic health care are examples of ex-
penditures that would help a far broader range of people than high-
tech fertility preservation.63 Ideally, these objectives would have high
priority in a reformed U.S. health care system. The public would then
non-elderly low-income parents, other caretaker relatives, pregnant women, and other non-dis-
abled adults.").
61. KAISER FAMILY FOUND. & GEORGE WASHINGTON UNIV. MED. CTR. SCH. OF PUB.
HEALTH & HEALTH SERVS., STATE MEDICAID COVERAGE OF FAMILY PLANNING SERVICES:
SUMMARY OF STATE FINDINGS, at tbl.4 (2009), available at http://www.kff.org/womenshealth/
8015.cfm.
62. See generally DEBORA L. SPAR, THE BABY BUSINESS: How MONEY, SCIENCE, AND POLIT-
Ics DRIVE THE COMMERCE OF CONCEPTION (2006); Michael J. Sandel, The Case Against Perfec-
tion: What's Wrong with Designer Children, Bionic Athletes, and Genetic Engineering, ATLANTIC
MONTHLY, Apr. 2004, at 51.
63. See Link & Phelan, supra note 56, at 80 ("When we create interventions that are expensive
and difficult to distribute broadly, we create health disparities."); see also Elizabeth Heitman,
Infertility as a Public Health Problem: Why Assisted Reproductive Technologies Are Not the An-
swer, STAN. L. & POL'Y REV., no. 2, 1995, at 89, 96 ("By promoting research and education on
the causes of infertility, and providing programs to modify or prevent behaviors that increase
infertility-causing disease, the need for infertility treatment could be reduced and the medical
services provided more effectively."). Recognizing the persistence of health inequities despite
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have to evaluate the priority to give oncofertility, as well as other ex-
pensive high-tech procedures benefitting relatively few patients, in a
system providing universal health care.
IV. RACIAL INEQUALITY AND WOMEN OF COLOR
A related question is whether extending fertility preservation to
women of color would help to reduce racial gaps in reproductive
health or reinforce racial assumptions underlying high-tech reproduc-
tion and a misplaced faith in technological solutions to social
problems. There is a strong case for efforts to increase fertility preser-
vation among women of color because the use of ART is currently
marked by stark racial disparities. 64 Although black women are more
likely to be infertile than white women, they are less likely to use
high-tech reproduction-assisting technologies and have poorer success
rates when they do.6 5 Indeed, according to a 2010 Fertility and Steril-
ity report, infertility among black women in the United States has in-
creased in recent years while the rate among white women has
declined.66 Although black and Latina women may be less likely to
seek these services for cultural reasons, they also confront barriers be-
cause it is "more difficult to get an appointment, to take time off from
work, and to pay for treatment." 67 In addition, stereotypes of mater-
nal unfitness and repressive policies aimed at deterring black and La-
tina women from having children have historically devalued their
decisions to become mothers.68 Images of the promise and successes
of high-tech reproduction usually depict white babies; when black
children are mentioned in news stories about ART, they are usually
featured as the products of mistakes made by fertility clinics. 69 The
devaluation of minority childbearing has steered public policies and
improvements in medical care, Phelan and Link argue that we should prioritize health interven-
tions whose benefits do not depend on the personal resources of individuals.
64. CAHN, supra note 4, at 141-42. For an argument to extend access to ART in the global
context, see Amanda Fleetwood & Lisa Campo-Engelstein, The Impact of Infertility: Why ART
Should Be a Higher Priority for Women in the Global South, in ONCOFERTILITY: ETHICAL, LE-
GAL, SOCIAL, AND MEDICAL PERSPECTIVEs, supra note 1, at 237.
65. Samantha F. Butts & David B. Seifer, Racial and Ethnic Differences in Reproductive Po-
tential Across the Life Cycle, 93 FERTILITY & STERILITY 681 (2010).
66. David B. Seifer et al., Trends of Racial Disparities in Assisted Reproductive Technologies
Outcomes in Black Women Compared with White Women: Society for Assisted Reproductive
Technology 1999 and 2000 vs. 2004-2006, 93 FERTILITY & STERILITY 626 (2010).
67. Stacey A. Missmer et al., Cultural Factors Contributing to Health Care Disparities Among
Patients with Infertility in Midwestern United States, 95 FERTILITY & STERILITY 1943, 1943
(2011).
68. See generally ROBERTS, supra note 7; ELENA R. GUTI8RREZ, FERTILE MATrERS: THE
POLITICS OF MEXICAN-ORIGIN WOMEN's REPRODUClON (2008).
69. ROBERTS, supra note 7, at 250-52.
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clinical decision making away from making ART equally accessible to
women of color.70 Thus, the intersection of gender, class, and race in
the lives of these women creates a social context that imposes espe-
cially formidable barriers to fertility preservation.
There is evidence that many women of color wish to use ART but
are prevented by impediments to access. Studies have found that use
of reproduction-assisting technologies by African-American women
increases dramatically when these barriers are removed.7' For exam-
ple, a team of federal researchers discovered that African-American
women's use of ART services increased fourfold in the military health
care system where access to medical care is widely available compared
to the general ART population in the United States. 72
Yet racial disparities persist even with better insurance coverage of
ART. Insurance helps to reduce the racial gap, but it is not enough to
close it. One study found that "[e]ven in states with mandated insur-
ance coverage, the individuals who access IVF services tend to be
predominantly Caucasian, highly educated, and wealthy."7 3 A 2006
study similarly concluded, "[W]e find no evidence that these mandates
have mitigated the disparities in access to treatment by race, ethnicity,
or SES [socioeconomic status] (as proxied by education)." 74 The au-
thors noted that further research is needed to explore why mandates
do not reduce racial disparities in access. A likely reason is that highly
educated, affluent white women are the group most likely to have pri-
vate health insurance. Women of color are more likely to rely on
Medicaid for their health care or be uninsured.75 Far from receiving
70. Id.; Nanette R. Elster, ART for the Masses?: Racial and Ethnic Inequality in Assisted Re-
productive Technologies, 9 DEPAUL J. HEALTH CARE L. 719 (2005); Lisa C. Ikemoto, The
In/Fertile, The Too Fertile, and The Dysfertile, 47 HASTINGS L.J. 1007 (1996).
71. Eve C. Feinberg et al., Comparison of Assisted Reproductive Technology Utilization and
Outcomes Between Caucasian and African American Patients in an Equal-Access-to-Care Setting,
85 FERTILITY & STERILITY 888 (2006) (finding an increase in African-American but not Latina
women's use of ART); Desired M. McCarthy-Keith et al., Will Decreasing Assisted Reproductive
Technology Costs Improve Utilization and Outcomes Among Minority Women?, 94 FERTILITY &
STERILITY 2587 (2010) (same).
72. Feinberg et al., supra note 71, at 893.
73. Victor Y. Fujimoto et al., Proceedings from the Conference on Reproductive Problems in
Women of Color, 94 FERTILITY & STERILITY 7, 7 (2010).
74. Marianne Bitler & Lucie Schmidt, Health Disparities and Infertility: Impacts of State-Level
Insurance Mandates, 85 FERTILITY & STERILITY 858, 864 (2006).
75. CARMEN DENAVAS-WALT ET AL., U.S. CENSUS BUREAU, INCOME, POVERTY, AND
HEALTH INSURANCE COVERAGE IN THE UNITED STATES: 2009, at 25 (2010), available at http://
www.census.gov/prod/2010pubs/p60-238.pdf; James B. Kirby & Toshiko Kaneda, Unhealthy and
Uninsured: Exploring Racial Differences in Health and Health Insurance Coverage Using a Life
Table Approach, 47 DEMOGRAPHY 1035 (2010).
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subsidies to increase their fertility, these women are subject to govern-
ment policies deterring them from having children.
Another possible reason for the persistent racial gap in ART use is
bias against patients of color, which leads physicians to devalue these
patients' childbearing or the importance of giving them information
about fertility preservation.76 In a study of doctor-patient communi-
cation about oncofertility, sociologist Karrie Ann Snyder found that
even in a sample of middle-class women with private insurance Afri-
can-American women were far less likely to discuss fertility preserva-
tion and more likely to have superficial discussions with their doctors
than white women.77
Equalizing access is also insufficient because racial disparities
plague the outcomes of infertility treatment. As troubling as the gap
in the use of ART is the finding that African-American women have
significantly lower live-birth rates after IVF than white women.78 Sev-
eral studies found "significant reductions (25%-38%) in African
American live-birth rates after IVF when compared with Caucasian
cohorts." 79 As a team of researchers concluded, "Improved access
may not translate into improved outcomes in some ethnic groups."80
The racial disparity in live births probably stems from the staggering
racial inequities that exist in overall health and access to health care in
the United States."' In addition to their greater reliance on Medicaid,
76. Dorothy E. Roberts, Reconstructing the Patient: Starting with Women of Color, in FEMI-
NISM & BIOETHICS: BEYOND REPRODUCTION 116 (Susan M. Wolf ed., 1996). On racial bias in
medical care, see JOHN HOBERMAN, BLACK AND BLUE: THE ORIGINS AND CONSEQUENCES OF
MEDICAL RACISM (2012); HARRIET WASHINGTON, MEDICAL APARTHEID: THE DARK HISTORY
OF MEDICAL EXPERIMENTATION ON BLACK AMERICANS FROM COLONIAL TIMES TO THE PRE-
SENT (2006).
77. Karrie Ann Snyder, Talk presented at Northwestern Oncofertility Consortium Annual
Conference: The Patient-Physician Interface: How Breast Cancer Patients Navigate Fertility
Concerns and Treatment Options (Sept. 12, 2011), available at http://oncofertility.northwestern.
edu/media/patient-physician-interface-how-breast-cancer-patients-navigate-fertility-concerns-
and-treat-0; see also CAHN, supra note 4, at 142 (discussing reasons why African-American
women may be uncomfortable discussing infertility with their doctors); Arthur L. Greil et al.,
Race-Ethnicity and Medical Services for Infertility: Stratified Reproduction in a Population-Based
Sample of U.S. Women, 52 J. HEALTH & Soc. BEHAv. 493 (2011) (discussing a study investigat-
ing attitudinal, social, and interpersonal pathways connecting race-ethnicity and medical services
for infertility).
78. Butts & Seifer, supra note 65; Victor Y. Fujimoto et al., Racial and Ethnic Disparities in
Assisted Reproductive Technology Outcomes in the United States, 93 FERTILITY & STERILITY 382
(2010); McCarthy-Keith et al., supra note 71; Seifer et al., supra note 66.
79. Fujimoto et al., supra note 73, at 8.
80. McCarthy-Keith et al., supra note 71, at 2587.
81. See generally DONALD A. BARR, HEALTH DISPARITIES IN THE UNITED STATES: SOCIAL
CLASS, RACE, ETHNICITY, AND HEALTH (2008); INST. OF MED., UNEQUAL TREATMENT: CON-
FRONTING RACIAL AND ETHNIC DISPARITIES IN HEALTH CARE (Brian D. Smedley et al. eds.,
2003).
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which limits the availability of ART, women of color are more likely
to be in poor health and to receive lower quality health care, including
cancer treatment.82 As one article summarized:
Compared with Caucasian women, African-American women are
less likely to be diagnosed at an early age, have higher mortality
rates, and are more likely to be diagnosed before age 40 years. Af-
rican-American breast cancer survivors [less than] 50 years report
poorer physical quality of life than white survivors.83
Although black women in Chicago are slightly less likely than white
women to get breast cancer, black women are sixty-eight percent
more likely to die from it.84 The reason is that most black women in
Chicago live in segregated neighborhoods where they do not have ac-
cess to the cancer detection and care or the social determinants of
good health available to white women living in the city.85 A stagger-
ing death disparity exists in reproductive health as well. A 2010 Am-
nesty International report, Deadly Delivery, stated that "African-
American women . . . are nearly four times more likely to die of preg-
nancy-related complications than white women." 86
The racial gap in actual outcomes despite increased use of ART
raises troubling questions about the ethics of oncofertility considered
in its social context. Concentrating efforts on increasing insurance
coverage for fertility preservation, rather than on providing basic uni-
versal health care for everyone, privileges white women who currently
have far better access to high-quality medical care. This reality accen-
tuates the questions of just distribution of public resources asked in
Part III: should we devote state funds to high-tech fertility preserva-
tion when many people do not have access to the basic health care
needed to bear healthy children and enjoy good health as adults? Ad-
ding the particular experiences and needs of women of color reveals
that this question involves not only the inability to afford oncofertility,
but also race-based impediments to good health and high-quality
health care.
Think also about the higher rates of infertility among women of
color. It would be more effective to address this need by improving
82. ELEANOR HINTON Hoyrr & HILARY BEARD. HEALTH FIRST!: THE BLACK WOMAN'S
WELLNESs GUIDE 111-235 (2012).
83. Schover et al., supra note 20, at 4983.
84. Jocelyn Hirschman et al., The Black:White Disparity in Breast Cancer Mortality: The Ex-
ample of Chicago, 18 CANCER CAUSES & CONTROL 323, 325-26 (2007).
85. See David Ansell et al., A Community Effort to Reduce the Black/White Breast Cancer
Mortality Disparity in Chicago, 20 CANCER CAUSES & CONTROL 1681, 1686 (2009); Shane
Tritsch, The Deadly Difference, CHICAGO, Oct. 2007, at 120.
86. AMNESTY INT'L, DEADLY DELIVERY: THE MATERNAL HEALTH CARE CRISIS IN THE USA
1 (2010).
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the basic conditions that lead to their infertility, such as occupational
and environmental hazards, diseases, abysmal reproductive health
care in prisons, and complications following childbirth or abortion.87
Black and Latina women are also disproportionately forced to delay
childbearing by long prison sentences that keep them behind bars dur-
ing their most fertile years. 8 The focus on infertility caused by
delayed careers caters primarily to middle-class white women and ob-
scures the causes of infertility more common among women of color.89
Moreover, women of color are less able to afford to technologically
bypass the structural unfairness in the workplace that pressures some
women to delay childbearing. The luxury of high-tech fertility preser-
vation takes the place of widespread reforms that would increase all
women's employment options. Relying on expensive interventions
such as egg freezing to resolve the tensions between child raising and
work keeps women from joining together to demand radical change in
the sexual division of labor. As I noted in Killing the Black Body:
This reliance on high-tech intervention rather than improving basic
health and workplace conditions hurts not only Black women but all
women and, ultimately, all of our society. We would all benefit
from a health policy that redirected the billions of dollars currently
spent on fertility treatment toward eradicating the causes of infertil-
ity. We would all benefit from a view of family that valued loving
relationships, however created, rather than genes traded on the
market. We would all benefit from a work world that appreciated
mothers' care for children.90
This ethical critique of fertility preservation competes with ethical
reasons to enable women cancer survivors to restore their fertility de-
stroyed by disease and to make this technology widely available. Its
social context of gender, class, and race inequities shows that, at a
minimum, advocates for state support for oncofertility research and
services should work toward equalizing general health and access to
high-quality medical care along with access to fertility preservation. It
is also critical to democratize the public evaluation of these priorities
to include the views of poor women and women of color.
87. Heitman, supra note 63; Human Rights Program at Justice Now, Prisons as a Tool of
Reproductive Oppression, 5 STAN. J. C.R. & C.L. 309, 325-29 (2009).
88. Human Rights Program at Justice Now, supra note 87, at 329-34.
89. Heitman, supra note 63, at 89 (arguing that "incomplete conceptual definitions skew the
epidemiological data on infertility in ways that exaggerate the proportion of infertile couples
whom assisted reproductive technologies might help").
90. ROBERTS, supra note 7, at 292.
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V. CONCLUSION
Ethical consideration of oncofertility must place this technological
innovation in its social context. This Article shows that attending to
the gender, class, and race inequities that influence women's repro-
ductive health and decision making highlights several paradoxical ten-
sions that complicate the ethics of oncofertility. There are compelling
ethical reasons to restore women cancer survivors' capacity to have a
child, more easily preserved for men, and for the public to support
wide access to this restoration. Yet an investigation of the underlying
structural injustices that place many women in conditions of infertility,
poor health, and inadequate access to medical care raises questions
about whether this would be a just distribution of public resources.
We must consider whether eradicating these unjust conditions re-
quires focusing on systemic change rather than expensive technologi-
cal interventions. At a minimum, advocates for oncofertility must
ensure that patients receive full information about the risks of, and
alternatives to, egg freezing and support efforts to implement univer-
sal and equal access to high-quality health care, as well as the demo-
cratic governance of new human biotechnologies. Otherwise, this
form of high-tech reproduction can intensify inequalities by privileg-
ing people who are already the most economically and socially ad-
vantaged even if insurance coverage extends its reach.
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